
|Videos|June 22, 2016
Clyde Markowitz: What is NEDA and How Does it Help Patient Care
Author(s)Adam Hochron
As new treatments are developed for multiple sclerosis one of the questions has become how do you measure their success. A possible metric being developed is No Evidence of Disease Activity or NEDA.
Advertisement
As new treatments are developed for multiple sclerosis one of the questions has become how do you measure their success. A possible metric being developed is No Evidence of Disease Activity or NEDA.
Speaking at the annual meeting of the Consortium of Multiple Sclerosis Centers Clyde Markowitz, MD, from the University of Pennsylvania said that not only are there questions about what NEDA means but also which model of it provides the best and most definitive results to help guide a patient's care.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Berobenatide Monthly Dosing Shows Weight Loss Efficacy in VESPER Trials, With John Buse, MD, PhD
5


























































